Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Depressive Disorder and OPRM1[original query] |
|---|
| Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. The American journal of psychiatry 2010 May 167 (5): 565-73. Garriock Holly A, Tanowitz Michael, Kraft Jeffrey B, Dang Vu C, Peters Eric J, Jenkins Greg D, Reinalda Megan S, McGrath Patrick J, von Zastrow Mark, Slager Susan L, Hamilton Steven |
| Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients. Biological psychiatry 2010 Jun 67 (11): 1110-3. Perlis Roy H, Fijal Bonnie, Dharia Sweta, Heinloth Alexandra N, Houston John |
| Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder. Human psychopharmacology 2013 May 28 (3): 258-62. Cooper Alissa J, Rickels Karl, Lohoff Falk |
| Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events. Psychoneuroendocrinology 2014 Nov 49 141-9. Slavich George M, Tartter Molly A, Brennan Patricia A, Hammen Constan |
| Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools. The pharmacogenomics journal 2018 5 18 (5): 613-622. Bousman Chad A, Dunlop Boadie |
| Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. Journal of personalized medicine 2022 4 12 (4): . Del Casale Antonio, Paolini Marco, Gentile Giovanna, Borro Marina, Zocchi Clarissa, Fiaschè Federica, Padovano Alessio, Zoppi Teodolinda, Modesti Martina Nicole, De Luca Ottavia, Pomes Leda Marina, Brugnoli Roberto, Ferracuti Stefano, Girardi Paolo, Pompili Maurizio, Simmaco Mauriz |
- Page last reviewed:Feb 1, 2024
- Content source: